SEVERE WX : Wind Advisory View Alerts

Pfizer coronavirus vaccine news bodes well for other coronavirus vaccines, experts say

CNN's Dr. Sanjay Gupta spoke with Pfizer CEO Albert Bourla about the latest data on the company's coronavirus vaccine.

Posted: Nov 9, 2020 10:07 AM
Updated: Nov 9, 2020 11:15 PM


News that Pfizer's coronavirus vaccine strongly protects people against infection is good news for other vaccines being developed against the pandemic, Dr. Anthony Fauci said Monday.

Pfizer said its candidate vaccine was more than 90% effective in preventing infection in volunteers. It uses a never-before-approved technology called messenger RNA, or mRNA, to produce an immune response in people who are vaccinated.

'This shows that the mRNA platform actually does work. And there's another vaccine candidate, Moderna, that's using the same platform,' Fauci told CNN in a telephone interview.

Fauci's National Institute of Allergy and Infectious Diseases is working with Moderna and other companies to test their experimental vaccines.

The US federal government has invested $1.95 billion in Pfizer and BioNTech's vaccine but is not directly working to help its development.

The mRNA vaccine approach uses genetic material called mRNA to trick cells into producing bits of protein that look like pieces of the virus. The immune system learns to recognize and attack those bits and, in theory, would react fast to any actual infection.

'Really encouraged to see this exciting announcement. Assuming it's supported by the data then this not only represents a potential breakthrough for Pfizer/BioNTech, but also for vaccines in general,' vaccine expert Robin Shattock, whose team at Imperial College London is working on an mRNA vaccine against coronavirus, said in a statement.

'It also demonstrates the speed and utility of RNA vaccines technology,' Shattock added.

'This announcement certainly gives a boost to our own self-amplifying RNA vaccine program. Not yet the end game, but hopefully the beginning of global efforts to control this pandemic. A significant light at the end of the tunnel.'

There's a second reason the Pfizer results are good news for other vaccines. They show that using spike protein as a target was the right call, Fauci said.

'The other good thing about it is that an actual immune response to the spike protein is a protective response,' Fauci said.

The virus has a structure called the spike protein to grapple the cells it attacks. The mRNA vaccines make the body produce little copies of just that structure.

'Remember -- people were not sure that if you made an immune response against the spike protein that that's the best and most appropriate target for an actual vaccine,' Fauci added.

Targeting the spike

'The good news is that this is the spike protein target and virtually every one of the other vaccines that are being tested also use the spike protein as a target, whether it's expressed in mRNA or it's a soluble protein. The spike protein is used in all of them, which bodes well for all the other vaccines.'

The Coalition for Epidemic Preparedness Innovations or CEPI also said the findings were a good sign for other vaccines in the pipeline. 'We believe these interim results also increase the probability of success of other Covid-19 candidate vaccines which use a similar approach [pre-fusion spike as their immunogen], including all of the vaccines in the CEPI portfolio,' CEPI CEO Dr. Richard Hatchett said in a statement.

Four coronavirus vaccines are in advanced, Phase 3 trials in the US now. They are made by Pfizer, as well as Moderna, Johnson & Johnson and AstraZeneca. Plus Maryland-based Novavax is expected to start a US-based Phase 3 trial later this month. It has a trial underway in Britain.

Pfizer got such a quick indication that its coronavirus vaccine is highly protective against infection in part because the pandemic is so bad, Fauci said.

The data was revealed as part of what's called an interim analysis. These are pre-planned peeks at the data.

In this case, Pfizer had planned to have a look as soon as 62 people in its 44,000 volunteer trial developed Covid-19 infections. But before the company could even finish discussing its plans with the U.S. Food and Drug Administration, it said, 94 people had become infected within a week of getting their second dose of either vaccine or placebo.

Pfizer's Data and Safety Monitoring Board -- an outside team of experts who watch the trial with a neutral eye -- unblinded the data and saw that more than 90% of those cases were in people who had gotten placebo, or dummy shots.

That's a reflection of both the large size of Pfizer's trial and the rate of infection across the United States, which just passed its 10 millionth diagnosed case, Fauci said.

'An answer depends on the size of the trial and how many infections there are in the community,' he said. It's not clear if all the cases used by Pfizer for its interim analysis were in the United States. The company is also testing the vaccine in Brazil, South Africa, Japan and other countries.

'This was a trial that was geared to 44,000 people and we are in the middle of a major surge right now. Those two things together make it much more likely that you'll get an answer quickly, which is what happened -- we got an answer quickly,' Fauci added.

Fauci said he expects Pfizer to apply to the FDA for emergency use authorization within about a week and a half. That will make it two months since volunteers got their second doses of vaccine. The FDA has asked vaccine makers for two months of safety data before they apply for authorization.

New York Coronavirus Cases

County data is updated nightly.

Cases: 2769624

Reported Deaths: 57725
CountyCasesDeaths
Kings35194510985
Queens32876810428
Suffolk2593403697
Nassau2291983338
Bronx2142426810
New York1785074667
Westchester1494462357
Erie1283712079
Monroe1001491259
Richmond934401975
Orange63182944
Onondaga60869824
Rockland55960783
Dutchess38515513
Albany35159419
Oneida33993651
Niagara29625425
Broome28853437
Saratoga25582228
Schenectady19780248
Ulster19468293
Rensselaer17938197
Chautauqua15521197
Oswego14611138
Putnam13335101
St. Lawrence13331146
Chemung13197176
Steuben12958194
Ontario12079121
Jefferson11736108
Wayne10658105
Cattaraugus10337165
Cayuga9951114
Sullivan990390
Genesee8949146
Herkimer8587145
Clinton834948
Fulton8040115
Tompkins762561
Warren762198
Madison7614109
Livingston745977
Montgomery7406163
Washington698982
Tioga654874
Cortland619489
Allegany6191123
Columbia5880115
Orleans573096
Chenango572797
Franklin563027
Otsego557466
Wyoming551569
Greene507890
Delaware462553
Lewis431640
Seneca340069
Essex307338
Schoharie281624
Yates206134
Schuyler200720
Hamilton5253
Unassigned1482
Out of NY0340
Utica
Cloudy
36° wxIcon
Hi: 36° Lo: 30°
Feels Like: 36°
Oneonta
Mostly Cloudy
37° wxIcon
Hi: 39° Lo: 27°
Feels Like: 31°
Herkimer
Mostly Cloudy
36° wxIcon
Hi: 39° Lo: 32°
Feels Like: 36°
Old Forge
Mostly Cloudy
36° wxIcon
Hi: 31° Lo: 22°
Feels Like: 36°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather
2022 WKTV Golf Card only $99.99
Game Day Deals - New Deals Each Week
Stuff the Bus Locations
Saluting Those Who Are Proud 2 Serve